These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent. Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856 [No Abstract] [Full Text] [Related]
29. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease. Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986 [TBL] [Abstract][Full Text] [Related]
30. Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions. Burket MW; Brodmann M; Metzger C; Tan K; Jaff MR J Vasc Interv Radiol; 2016 Nov; 27(11):1650-1656.e1. PubMed ID: 27542591 [TBL] [Abstract][Full Text] [Related]
31. In vivo geometry of the kissing stent and covered endovascular reconstruction of the aortic bifurcation configurations in aortoiliac occlusive disease. Groot Jebbink E; Ter Mors TG; Slump CH; Geelkerken RH; Holewijn S; Reijnen MM Vascular; 2017 Dec; 25(6):635-641. PubMed ID: 28530484 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions. Tewksbury R; Taumoepeau L; Cartmill A; Butcher A; Cohen T Vascular; 2015 Dec; 23(6):630-6. PubMed ID: 25819513 [TBL] [Abstract][Full Text] [Related]
33. A Hybrid Technique to Treat Iliofemoral Lesions Using a Covered Stent Associated with Open Femoral Repair. Bosse C; Becquemin JP; Touma J; Desgranges P; Cochennec F Ann Vasc Surg; 2020 Jul; 66():601-608. PubMed ID: 31866550 [TBL] [Abstract][Full Text] [Related]
34. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. Mwipatayi BP; Sharma S; Daneshmand A; Thomas SD; Vijayan V; Altaf N; Garbowski M; Jackson M; J Vasc Surg; 2016 Jul; 64(1):83-94.e1. PubMed ID: 27131926 [TBL] [Abstract][Full Text] [Related]
35. Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease. Faries P; Jaff M; Peeters P; Khatib Y; Roberts D; Bosiers M; Malik R; Ravin R; Rundback J Ann Vasc Surg; 2018 Aug; 51():37-47. PubMed ID: 29678649 [TBL] [Abstract][Full Text] [Related]
36. Patency and limb salvage after femoral endarterectomy and iliac stenting are not affected by severity of iliac disease. Ilano AG; Garvin RP; Ryer EJ; Dove JT; Elmore JR J Vasc Surg; 2017 May; 65(5):1336-1343. PubMed ID: 28189354 [TBL] [Abstract][Full Text] [Related]
37. Update on diagnostics and treatment modalities for obstructive iliac artery disease. Ünlü Ҫ; de Vries JP J Cardiovasc Surg (Torino); 2018 Feb; 59(1):1-3. PubMed ID: 28933524 [No Abstract] [Full Text] [Related]
38. Endovascular revascularization for aortoiliac atherosclerotic disease. Aggarwal V; Waldo SW; Armstrong EJ Vasc Health Risk Manag; 2016; 12():117-27. PubMed ID: 27099509 [TBL] [Abstract][Full Text] [Related]
39. "Pseudo aortoiliac bifurcation" leading to significant plaque shifting in the endovascular treatment of an aortoiliac bifurcation lesion: a case report. Kadoya Y; Kenzaka T; Naito D; Zen K; Matoba S BMC Cardiovasc Disord; 2017 Jul; 17(1):179. PubMed ID: 28676079 [TBL] [Abstract][Full Text] [Related]
40. Impact of iliac artery anatomy on the outcome of fenestrated and branched endovascular aortic repair. Gallitto E; Gargiulo M; Faggioli G; Pini R; Mascoli C; Freyrie A; Ancetti S; Stella A J Vasc Surg; 2017 Dec; 66(6):1659-1667. PubMed ID: 28888759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]